Selected research
Industry Research
Batch Release Testing Industry Research Report 2026
Market perspective
The global Batch Release Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Batch Release Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Batch Release Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Batch Release Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Batch Release Testing include Samsung Biologics, Texcell, Intertek Group plc, ALS Life Sciences Europe, Kymos, Selvita, Excite Pharma Services, Smithers and BSL BIOSERVICE Scientific Laboratories Munich GmbH, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Batch Release Testing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Batch Release Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Batch Release Testing Market by Company
Samsung Biologics
Texcell
Intertek Group plc
ALS Life Sciences Europe
Kymos
Selvita
Excite Pharma Services
Smithers
BSL BIOSERVICE Scientific Laboratories Munich GmbH
FDAS
ALS Laboratories (UK) Limited
ADOH BV
Wuxi Biologics
Merk
Eurofins BioPharma Product Testing
Batch Release Testing Segment by Type
Full Batch Release
Sampling Release
Batch Release Testing Segment by Application
Biopharmaceutical
Scientific Research
Batch Release Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Batch Release Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Batch Release Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Batch Release Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Batch Release Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Full Batch Release
- Sampling Release
Applications
- Biopharmaceutical
- Scientific Research
Companies covered
- Samsung Biologics
- Texcell
- Intertek Group plc
- ALS Life Sciences Europe
- Kymos
- Selvita
- Excite Pharma Services
- Smithers
- BSL BIOSERVICE Scientific Laboratories Munich GmbH
- FDAS
- ALS Laboratories (UK) Limited
- ADOH BV
- Wuxi Biologics
- Merk
- Eurofins BioPharma Product Testing
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Batch Release Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Full Batch Release
- 2.2.3 Sampling Release
- 2.3 Batch Release Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Biopharmaceutical
- 2.3.3 Scientific Research
- 2.4 Assumptions and Limitations
3 Batch Release Testing Breakdown Data by Type
- 3.1 Global Batch Release Testing Historic Market Size by Type (2021-2026)
- 3.2 Global Batch Release Testing Forecasted Market Size by Type (2027-2032)
4 Batch Release Testing Breakdown Data by Application
- 4.1 Global Batch Release Testing Historic Market Size by Application (2021-2026)
- 4.2 Global Batch Release Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Batch Release Testing Market Perspective (2021-2032)
- 5.2 Global Batch Release Testing Growth Trends by Region
- 5.2.1 Global Batch Release Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Batch Release Testing Historic Market Size by Region (2021-2026)
- 5.2.3 Batch Release Testing Forecasted Market Size by Region (2027-2032)
- 5.3 Batch Release Testing Market Dynamics
- 5.3.1 Batch Release Testing Industry Trends
- 5.3.2 Batch Release Testing Market Drivers
- 5.3.3 Batch Release Testing Market Challenges
- 5.3.4 Batch Release Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Batch Release Testing Players by Revenue
- 6.1.1 Global Top Batch Release Testing Players by Revenue (2021-2026)
- 6.1.2 Global Batch Release Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global Batch Release Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Batch Release Testing Head Office and Area Served
- 6.4 Global Batch Release Testing Players, Product Type & Application
- 6.5 Global Batch Release Testing Manufacturers Established Date
- 6.6 Global Batch Release Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Batch Release Testing Market Size (2021-2032)
- 7.2 North America Batch Release Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Batch Release Testing Market Size by Country (2021-2026)
- 7.4 North America Batch Release Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Batch Release Testing Market Size (2021-2032)
- 8.2 Europe Batch Release Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Batch Release Testing Market Size by Country (2021-2026)
- 8.4 Europe Batch Release Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Batch Release Testing Market Size (2021-2032)
- 9.2 Asia-Pacific Batch Release Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Batch Release Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Batch Release Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Batch Release Testing Market Size (2021-2032)
- 10.2 South America Batch Release Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Batch Release Testing Market Size by Country (2021-2026)
- 10.4 South America Batch Release Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Batch Release Testing Market Size (2021-2032)
- 11.2 Middle East & Africa Batch Release Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Batch Release Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Batch Release Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Samsung Biologics
- 12.1.1 Samsung Biologics Company Information
- 12.1.2 Samsung Biologics Business Overview
- 12.1.3 Samsung Biologics Revenue in Batch Release Testing Business (2021-2026)
- 12.1.4 Samsung Biologics Batch Release Testing Product Portfolio
- 12.1.5 Samsung Biologics Recent Developments
- 12.2 Texcell
- 12.2.1 Texcell Company Information
- 12.2.2 Texcell Business Overview
- 12.2.3 Texcell Revenue in Batch Release Testing Business (2021-2026)
- 12.2.4 Texcell Batch Release Testing Product Portfolio
- 12.2.5 Texcell Recent Developments
- 12.3 Intertek Group plc
- 12.3.1 Intertek Group plc Company Information
- 12.3.2 Intertek Group plc Business Overview
- 12.3.3 Intertek Group plc Revenue in Batch Release Testing Business (2021-2026)
- 12.3.4 Intertek Group plc Batch Release Testing Product Portfolio
- 12.3.5 Intertek Group plc Recent Developments
- 12.4 ALS Life Sciences Europe
- 12.4.1 ALS Life Sciences Europe Company Information
- 12.4.2 ALS Life Sciences Europe Business Overview
- 12.4.3 ALS Life Sciences Europe Revenue in Batch Release Testing Business (2021-2026)
- 12.4.4 ALS Life Sciences Europe Batch Release Testing Product Portfolio
- 12.4.5 ALS Life Sciences Europe Recent Developments
- 12.5 Kymos
- 12.5.1 Kymos Company Information
- 12.5.2 Kymos Business Overview
- 12.5.3 Kymos Revenue in Batch Release Testing Business (2021-2026)
- 12.5.4 Kymos Batch Release Testing Product Portfolio
- 12.5.5 Kymos Recent Developments
- 12.6 Selvita
- 12.6.1 Selvita Company Information
- 12.6.2 Selvita Business Overview
- 12.6.3 Selvita Revenue in Batch Release Testing Business (2021-2026)
- 12.6.4 Selvita Batch Release Testing Product Portfolio
- 12.6.5 Selvita Recent Developments
- 12.7 Excite Pharma Services
- 12.7.1 Excite Pharma Services Company Information
- 12.7.2 Excite Pharma Services Business Overview
- 12.7.3 Excite Pharma Services Revenue in Batch Release Testing Business (2021-2026)
- 12.7.4 Excite Pharma Services Batch Release Testing Product Portfolio
- 12.7.5 Excite Pharma Services Recent Developments
- 12.8 Smithers
- 12.8.1 Smithers Company Information
- 12.8.2 Smithers Business Overview
- 12.8.3 Smithers Revenue in Batch Release Testing Business (2021-2026)
- 12.8.4 Smithers Batch Release Testing Product Portfolio
- 12.8.5 Smithers Recent Developments
- 12.9 BSL BIOSERVICE Scientific Laboratories Munich GmbH
- 12.9.1 BSL BIOSERVICE Scientific Laboratories Munich GmbH Company Information
- 12.9.2 BSL BIOSERVICE Scientific Laboratories Munich GmbH Business Overview
- 12.9.3 BSL BIOSERVICE Scientific Laboratories Munich GmbH Revenue in Batch Release Testing Business (2021-2026)
- 12.9.4 BSL BIOSERVICE Scientific Laboratories Munich GmbH Batch Release Testing Product Portfolio
- 12.9.5 BSL BIOSERVICE Scientific Laboratories Munich GmbH Recent Developments
- 12.10 FDAS
- 12.10.1 FDAS Company Information
- 12.10.2 FDAS Business Overview
- 12.10.3 FDAS Revenue in Batch Release Testing Business (2021-2026)
- 12.10.4 FDAS Batch Release Testing Product Portfolio
- 12.10.5 FDAS Recent Developments
- 12.11 ALS Laboratories (UK) Limited
- 12.11.1 ALS Laboratories (UK) Limited Company Information
- 12.11.2 ALS Laboratories (UK) Limited Business Overview
- 12.11.3 ALS Laboratories (UK) Limited Revenue in Batch Release Testing Business (2021-2026)
- 12.11.4 ALS Laboratories (UK) Limited Batch Release Testing Product Portfolio
- 12.11.5 ALS Laboratories (UK) Limited Recent Developments
- 12.12 ADOH BV
- 12.12.1 ADOH BV Company Information
- 12.12.2 ADOH BV Business Overview
- 12.12.3 ADOH BV Revenue in Batch Release Testing Business (2021-2026)
- 12.12.4 ADOH BV Batch Release Testing Product Portfolio
- 12.12.5 ADOH BV Recent Developments
- 12.13 Wuxi Biologics
- 12.13.1 Wuxi Biologics Company Information
- 12.13.2 Wuxi Biologics Business Overview
- 12.13.3 Wuxi Biologics Revenue in Batch Release Testing Business (2021-2026)
- 12.13.4 Wuxi Biologics Batch Release Testing Product Portfolio
- 12.13.5 Wuxi Biologics Recent Developments
- 12.14 Merk
- 12.14.1 Merk Company Information
- 12.14.2 Merk Business Overview
- 12.14.3 Merk Revenue in Batch Release Testing Business (2021-2026)
- 12.14.4 Merk Batch Release Testing Product Portfolio
- 12.14.5 Merk Recent Developments
- 12.15 Eurofins BioPharma Product Testing
- 12.15.1 Eurofins BioPharma Product Testing Company Information
- 12.15.2 Eurofins BioPharma Product Testing Business Overview
- 12.15.3 Eurofins BioPharma Product Testing Revenue in Batch Release Testing Business (2021-2026)
- 12.15.4 Eurofins BioPharma Product Testing Batch Release Testing Product Portfolio
- 12.15.5 Eurofins BioPharma Product Testing Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst